GOLDMAN SACHS GROUP INC - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 129 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,705,102
+145.5%
1,114,953
+80.4%
0.00%
Q2 2023$1,916,333
+129.6%
618,172
+3.0%
0.00%
Q1 2023$834,559
-37.1%
600,402
-9.9%
0.00%
Q4 2022$1,326,074
+6.9%
666,369
+8.5%
0.00%
Q3 2022$1,241,000
-47.9%
614,380
-17.9%
0.00%
-100.0%
Q2 2022$2,381,000
-27.2%
748,655
-4.5%
0.00%0.0%
Q1 2022$3,270,000
-30.6%
784,082
-20.3%
0.00%0.0%
Q4 2021$4,712,000
-6.2%
983,796
+4.6%
0.00%0.0%
Q3 2021$5,023,000
+43.2%
940,630
+37.3%
0.00%0.0%
Q2 2021$3,508,000
+25.1%
685,079
+64.3%
0.00%0.0%
Q1 2021$2,805,000
-14.4%
416,904
-41.8%
0.00%0.0%
Q4 2020$3,276,000
+153.6%
716,815
+115.3%
0.00%
Q3 2020$1,292,000
+64.0%
332,956
+101.3%
0.00%
Q2 2020$788,000
-56.1%
165,393
-67.9%
0.00%
-100.0%
Q1 2020$1,795,000
+9.7%
515,787
+51.9%
0.00%
Q4 2019$1,636,000
+56.4%
339,452
-5.9%
0.00%
Q3 2019$1,046,000
-35.7%
360,635
+58.8%
0.00%
Q2 2019$1,628,000
-66.1%
227,154
-33.0%
0.00%
-100.0%
Q1 2019$4,802,000
-13.2%
338,834
-17.1%
0.00%
-50.0%
Q4 2018$5,532,000
-10.1%
408,861
+47.5%
0.00%0.0%
Q3 2018$6,151,000
+83.0%
277,175
+35.3%
0.00%
+100.0%
Q2 2018$3,362,000204,8280.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$144,839,00011.40%
Eversept Partners, LP 4,755,480$32,004,3802.41%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$109,116,0001.27%
EAM Global Investors LLC 365,719$2,461,0000.68%
Signature Wealth Management Partners, LLC 87,666$590,0000.57%
Jackson Creek Investment Advisors LLC 221,043$1,488,0000.52%
Tranquilli Financial Advisor LLC 71,414$481,0000.39%
Hillsdale Investment Management Inc. 611,200$4,113,0000.34%
EAM Investors, LLC 259,873$1,749,0000.26%
HUSSMAN STRATEGIC ADVISORS, INC. 180,000$1,211,0000.25%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders